Vignesh Packiam, MD, discusses strategies to manage intravesical therapy toxicity in NMIBC, improve treatment tolerability, and preserve bladder function.
|Podcasts|May 26, 2022
Dr. Lutz on sexual dysfunction, performance anxiety, and Peyronie's disease
Author(s)Urology Times staff
“We know that erectile dysfunction is really an important issue that can be a harbinger for other underlying cardiovascular or neurological health issues,” says Michael Lutz, MD.
Advertisement
In this episode, Urology Times® Assistant Managing Editor Ben Saylor spoke with Michael Lutz, MD, regarding current topics in sexual dysfunction. Lutz is a partner in the Michigan Institute of Urology and President of the MIU Men’s Health Foundation.
Advertisement
Related to this article
Peter Clark, MD, discusses key updates to NMIBC guidelines, including revisions to risk stratification, the emerging role of biomarkers, and how to navigate treatment options for BCG-unresponsive disease.
Advertisement
Advertisement
Trending on Urology Times
1
How PSMA-PET shapes staging and recurrence workup in prostate cancer
2
European Commission approves perioperative pembrolizumab plus enfortumab vedotin for MIBC
3
Engy Habashy, MD, on the role of androgens in GSM management
4
ESMO 2026: Key presentations across genitourinary oncology
5